Guangzhou Bio-gene Technology Co., Ltd

This early-stage study is testing a new type of CAR-T cell therapy for adults with multiple myeloma that has come back or stopped responding to other treatments. The therapy involves modifying a patient's own immune cells to attack the cancer by targeting two specific markers on …

This early-stage study is testing the safety and initial effectiveness of a new type of CAR-T cell therapy for people with relapsed or refractory multiple myeloma. The therapy involves collecting a patient's own immune cells, modifying them in a lab to target two proteins on myel…

This early-stage study is testing the safety and initial effectiveness of a new type of CAR-T cell therapy called BAFFR CAR-T in adults with B-cell leukemia or lymphoma that has come back or not responded to standard treatments. Doctors will give the therapy to a small group of p…